Downregulation of Lymphoid enhancer‐binding factor 1 ( LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features-Reference-Cited by-同舟云学术

Downregulation of Lymphoid enhancer‐binding factor 1 ( LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features

Published:2020-12-12 Issue:3 Volume:43 Page:515-525
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hem

Author:

Soliman Dina S.¹²³^ORCID,Al‐Kuwari Einas⁴,Siveen Kodappully S⁵,Al‐Abdulla Rajaa⁴,Chandra Prem⁶,Yassin Mohamed⁷,Nashwan Abdulqader⁸,Hilmi Feryal A¹,Taha Ruba Y⁷,Nawaz Zafar⁴,El‐Omri Halima⁷,Mateo Jericha M⁵,Al‐Sabbagh Ahmad¹

Affiliation:

1. Department of Laboratory Medicine and Pathology National Center for Cancer Care and Research Hamad Medical Corporation Doha Qatar

2. Weill Cornell Medicine – Qatar Doha Qatar

3. Department of Clinical Pathology National Cancer Institute Cairo Egypt

4. Department of Laboratory Medicine and Pathology Hamad Medical Corporation Doha Qatar

5. Flow Cytometry Core Facility interim Translational Research Institute Hamad Medical Corporation Doha Qatar

6. Medical Research Center Academic Health Systems Hamad Medical Corporation Doha Qatar

7. Department of Hematology and Medical Oncology National Center for Cancer Care and Research Hamad Medical Corporation Doha Qatar

8. Nursing Department Hazm Mebaireek General Hospital Hamad Medical Corporation Doha Qatar

Funder

Qatar National Research Fund

Hamad Medical Corporation

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13420

Reference31 articles.

1. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

2. Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b)

3. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients

4. Small B-Cell Neoplasms With Typical Mantle Cell Lymphoma Immunophenotypes Often Include Chronic Lymphocytic Leukemias

5. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment for acceleration and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma using histologic and immunohistochemical features: a case series;Journal of Hematopathology;2024-07-23

2. The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype;Scientific Reports;2024-06-11

3. Leukemic-phase mucosa-associated lymphoid tissue lymphoma;International Journal of Hematology;2023-09-12

4. Atypical Chronic Lymphocytic Leukemia—The Current Status;Cancers;2023-09-05

5. Updates in Immunohistochemistry for Hematopoietic and Lymphoid Neoplasms;Archives of Pathology & Laboratory Medicine;2023-06-01